ArticleEye and vision (London, England)2021
Five-year outcomes of EVO implantable collamer lens implantation for the correction of high myopia and super high myopia.
Article in Eye and vision (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 49 citations in OpenAlex.
- Application of directional customized corneal relaxing incision in EVO ICL implantation: high myopia with low astigmatism.BMC ophthalmology · 2026Trial
- The EVO ICL for Moderate Myopia: Results from the US FDA Clinical Trial.Clinical ophthalmology (Auckland, N.Z.) · 2022Trial
- Implantable collamer lens combined with femtosecond laser-assisted arcuate keratotomy and toric implantable collamer lens for high myopia with moderate-to-low astigmatism corrections: a comparative study.BMC ophthalmology · 2026Article
- Artificial intelligence in refractive surgery: progress, challenges, and future directions.Frontiers in cell and developmental biology · 2026Review
- Long-Term Evaluation of Contrast Sensitivity and Vision Quality for High and Extreme High Myopia After EVO ICL Implantation.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction.Annals of medicine · 2025Article
- Real-World Safety Profile of EVO and EVO+ Implantable Collamer Lenses: A Retrospective Study Based on FDA Surveillance Data.Ophthalmology and therapy · 2025Article
- Haptics and axis stability of customized vertical implantable collamer lens implantation.Journal of cataract and refractive surgery · 2025Article
- Long-term observation of glare and dynamic pupil after EVO ICL (implantable collamer lens) for myopia.BMC ophthalmology · 2025Article
- Effects of crystalline lens characteristics on vault after implantable collamer lens implantation.BMC ophthalmology · 2025Observational
- Long-term changes in classified higher-order aberrations after implanting an EVO intraocular collamer lens.BMC ophthalmology · 2025Article
- Characteristics of biological parameters and implantable collamer lens (ICL) size selection in moderate, high, and super-high myopia eyes.BMC ophthalmology · 2025Observational
- Femtosecond laser versus manual clear corneal incision in implantable collamer lens surgery.Scientific reports · 2025Article
- Visual related quality of life after ICL V4c implantation in high myopia patients: a mini review.Frontiers in medicine · 2025Review
- Femtosecond laser assisted cataract surgery in a cataract patient with low vaulted ICL following LASIK: a case report.BMC ophthalmology · 2024Article
- Article
- Predicting Implantable Collamer Lens Vault Using Machine Learning Based on Various Preoperative Biometric Factors.Translational vision science & technology · 2024Article
- Bibliometric and visualized analysis of posterior chamber phakic intraocular lens research between 2003 and 2023.Frontiers in medicine · 2024Review
- Effects of clear corneal incision location and morphology on corneal surgically induced astigmatism and higher-order aberrations after ICL V4c implantation.Frontiers in medicine · 2024Article
- Five-year follow-up of a posterior chamber phakic intraocular lens with a central hole for correction of myopia.International ophthalmology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 2 countries.
Funding
Abstract
backgroundTo evaluate the long-term safety, efficacy, predictability, and stability of implantable collamer lens with a central hole (EVO ICL) implantation for correcting high myopia (HM) and super high myopia (SHM).
methodsThis prospective study evaluated 83 eyes of 46 patients who were divided into groups based on their spherical equivalent refractive error (SE): HM group (- 12 D ≤ SE < - 6 D) and SHM group (SE < - 12 D). They were followed up for 5 years after ICL implantation; assessments of uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refractive error, axial length, intraocular pressure, corneal endothelial cell density, and vault were conducted, and a questionnaire was administered. RESUITS: At 5 years postoperatively, the safety indices of the HM and SHM groups were 1.03 ± 0.10 and 1.32 ± 0.39, and the efficacy indices were 0.83 ± 0.25 and 0.86 ± 0.32, respectively. In the HM group, 60.47% and 79.07% of the eyes were within ± 0.50 D and ± 1.00 D of the attempted correction, while it was achieved for 22.50% and 47.50% of the eyes in the SHM group, respectively. The SE of the HM group decreased from - 9.72 ± 1.41 D preoperatively to 0.04 ± 0.39 D 1 month postoperatively and - 0.67 ± 0.57 D 5 years postoperatively, while in the SHM group, it decreased from - 15.78 ± 3.06 D preoperatively to - 0.69 ± 0.97 D 1 month postoperatively and - 1.74 ± 1.19 D 5 years postoperatively.
conclusionEVO ICL implantation is safe, effective, and predictable for correcting HM and SHM. CDVA improved more after surgery for SHM, but the growth of axial length still needs attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.